JP2020073494A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020073494A5 JP2020073494A5 JP2019224873A JP2019224873A JP2020073494A5 JP 2020073494 A5 JP2020073494 A5 JP 2020073494A5 JP 2019224873 A JP2019224873 A JP 2019224873A JP 2019224873 A JP2019224873 A JP 2019224873A JP 2020073494 A5 JP2020073494 A5 JP 2020073494A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- aqueous pharmaceutical
- composition according
- pirfenidone
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 23
- 239000007788 liquid Substances 0.000 claims 11
- 230000008685 targeting Effects 0.000 claims 8
- 239000000443 aerosol Substances 0.000 claims 7
- ISWRGOKTTBVCFA-UHFFFAOYSA-N pirfenidone Chemical compound C1=C(C)C=CC(=O)N1C1=CC=CC=C1 ISWRGOKTTBVCFA-UHFFFAOYSA-N 0.000 claims 7
- 229960003073 pirfenidone Drugs 0.000 claims 7
- 239000003446 ligand Substances 0.000 claims 6
- 239000006199 nebulizer Substances 0.000 claims 6
- 150000003384 small molecules Chemical class 0.000 claims 5
- 208000029523 Interstitial Lung disease Diseases 0.000 claims 3
- 239000007864 aqueous solution Substances 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 210000004072 lung Anatomy 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 229940126864 fibroblast growth factor Drugs 0.000 claims 2
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 claims 2
- 239000006186 oral dosage form Substances 0.000 claims 2
- 230000003204 osmotic effect Effects 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims 2
- BLUGYPPOFIHFJS-UUFHNPECSA-N (2s)-n-[(2s)-1-[[(3r,4s,5s)-3-methoxy-1-[(2s)-2-[(1r,2r)-1-methoxy-2-methyl-3-oxo-3-[[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamid Chemical compound CN[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C=1SC=CN=1)CC1=CC=CC=C1 BLUGYPPOFIHFJS-UUFHNPECSA-N 0.000 claims 1
- 208000007934 ACTH-independent macronodular adrenal hyperplasia Diseases 0.000 claims 1
- 102100031168 CCN family member 2 Human genes 0.000 claims 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims 1
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 claims 1
- 101000777550 Homo sapiens CCN family member 2 Proteins 0.000 claims 1
- 101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 claims 1
- 101001092910 Homo sapiens Serum amyloid P-component Proteins 0.000 claims 1
- -1 IW001 Proteins 0.000 claims 1
- 108010005716 Interferon beta-1a Proteins 0.000 claims 1
- 102000008070 Interferon-gamma Human genes 0.000 claims 1
- 108010074328 Interferon-gamma Proteins 0.000 claims 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims 1
- 102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 claims 1
- 108010089484 PRM-151 Proteins 0.000 claims 1
- 102100036202 Serum amyloid P-component Human genes 0.000 claims 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 229910001622 calcium bromide Inorganic materials 0.000 claims 1
- 239000001110 calcium chloride Substances 0.000 claims 1
- 229910001628 calcium chloride Inorganic materials 0.000 claims 1
- WGEFECGEFUFIQW-UHFFFAOYSA-L calcium dibromide Chemical compound [Ca+2].[Br-].[Br-] WGEFECGEFUFIQW-UHFFFAOYSA-L 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 239000006184 cosolvent Substances 0.000 claims 1
- 230000008021 deposition Effects 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 229960004461 interferon beta-1a Drugs 0.000 claims 1
- 229960003130 interferon gamma Drugs 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 claims 1
- 229910001623 magnesium bromide Inorganic materials 0.000 claims 1
- 229910001629 magnesium chloride Inorganic materials 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- XZXHXSATPCNXJR-ZIADKAODSA-N nintedanib Chemical compound O=C1NC2=CC(C(=O)OC)=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1N(C)C(=O)CN1CCN(C)CC1 XZXHXSATPCNXJR-ZIADKAODSA-N 0.000 claims 1
- 229960004378 nintedanib Drugs 0.000 claims 1
- 239000008363 phosphate buffer Substances 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 239000006068 taste-masking agent Substances 0.000 claims 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 230000001256 tonic effect Effects 0.000 claims 1
- 239000000080 wetting agent Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022024945A JP2022078126A (ja) | 2012-07-24 | 2022-02-21 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
| JP2024040308A JP2024095678A (ja) | 2012-07-24 | 2024-03-14 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261675286P | 2012-07-24 | 2012-07-24 | |
| US61/675,286 | 2012-07-24 | ||
| US201361756983P | 2013-01-25 | 2013-01-25 | |
| US61/756,983 | 2013-01-25 | ||
| US201361824818P | 2013-05-17 | 2013-05-17 | |
| US61/824,818 | 2013-05-17 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018116525A Division JP2018172402A (ja) | 2012-07-24 | 2018-06-19 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022024945A Division JP2022078126A (ja) | 2012-07-24 | 2022-02-21 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020073494A JP2020073494A (ja) | 2020-05-14 |
| JP2020073494A5 true JP2020073494A5 (enExample) | 2020-11-26 |
| JP7120984B2 JP7120984B2 (ja) | 2022-08-17 |
Family
ID=49997965
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015524425A Active JP6501264B2 (ja) | 2012-07-24 | 2013-07-24 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
| JP2018116525A Pending JP2018172402A (ja) | 2012-07-24 | 2018-06-19 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
| JP2019224873A Active JP7120984B2 (ja) | 2012-07-24 | 2019-12-12 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
| JP2022024945A Pending JP2022078126A (ja) | 2012-07-24 | 2022-02-21 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
| JP2024040308A Pending JP2024095678A (ja) | 2012-07-24 | 2024-03-14 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015524425A Active JP6501264B2 (ja) | 2012-07-24 | 2013-07-24 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
| JP2018116525A Pending JP2018172402A (ja) | 2012-07-24 | 2018-06-19 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022024945A Pending JP2022078126A (ja) | 2012-07-24 | 2022-02-21 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
| JP2024040308A Pending JP2024095678A (ja) | 2012-07-24 | 2024-03-14 | エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2877164B1 (enExample) |
| JP (5) | JP6501264B2 (enExample) |
| AU (5) | AU2013295800A1 (enExample) |
| CA (1) | CA2880011C (enExample) |
| ES (1) | ES2959198T3 (enExample) |
| HU (1) | HUE063581T2 (enExample) |
| NZ (1) | NZ705260A (enExample) |
| WO (1) | WO2014018668A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6021117B2 (ja) | 2011-01-31 | 2016-11-02 | ジェノア ファーマシューティカルズ，インク． | エアロゾルのピルフェニドンおよびピリドンアナログの化合物、および、その使用 |
| US10105356B2 (en) | 2011-01-31 | 2018-10-23 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| US20150044288A1 (en) | 2013-07-31 | 2015-02-12 | Windward Pharma, Inc. | Aerosol tyrosine kinase inhibitor compounds and uses thereof |
| EP4491180A1 (en) | 2014-01-10 | 2025-01-15 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| KR102373700B1 (ko) | 2014-04-02 | 2022-03-11 | 인터뮨, 인크. | 항섬유성 피리디논 |
| WO2017172826A1 (en) * | 2016-03-28 | 2017-10-05 | Presage Biosciences, Inc. | Pharmaceutical combinations for the treatment of cancer |
| WO2018071427A1 (en) * | 2016-10-11 | 2018-04-19 | Microdose Therapeutx, Inc. | Inhaler and methods of use thereof |
| EP3641946B1 (en) * | 2017-06-22 | 2025-04-30 | invoX Belgium NV | PIRFENIDONE AEROSOL ADMINISTRATION |
| WO2018234527A1 (en) * | 2017-06-22 | 2018-12-27 | Softhale Nv | Aerosol delivery of pirfenidone |
| GB201807050D0 (en) * | 2018-04-30 | 2018-06-13 | Cellprotect Nordic Pharmaceuticals Ab | Medical uses |
| EP3958867B1 (en) | 2019-04-24 | 2024-06-26 | Convergene Llc | Small molecule bromodomain inhibitors and uses thereof |
| EP3976570A1 (en) * | 2019-05-27 | 2022-04-06 | DSM IP Assets B.V. | Selective hydrogenation of alkynes to alkenes in the presence of a phosphorus compound and an organic sulphur compound |
| KR102584268B1 (ko) * | 2020-04-22 | 2023-10-05 | 영진약품 주식회사 | 안전성과 안정성이 개선된 피르페니돈을 포함하는 장용성 제제 및 이의 제조방법 |
| CN116600790A (zh) * | 2020-12-07 | 2023-08-15 | 满康德股份有限公司 | 治疗肺纤维化的方法和组合物 |
| US20230310322A1 (en) * | 2022-03-30 | 2023-10-05 | The Chinese University Of Hong Kong | Pfd loaded microspheres and method for preparing injectable composite microsphere hydrogel solution from same |
| CN115970069B (zh) * | 2022-12-13 | 2024-09-24 | 南通大学附属医院 | 载吡非尼酮纳米粒子复合涂层输尿管支架管的制备方法 |
| CN119548479A (zh) * | 2024-12-31 | 2025-03-04 | 延边大学 | 一种吸入用吡非尼酮溶液及其使用方法 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3826255A (en) | 1972-06-22 | 1974-07-30 | Hudson Oxygen Therapy Sales Co | Intermittent positive pressure breathing manifold |
| YU41046B (en) | 1974-08-22 | 1986-10-31 | Schering Ag | Medicine inholating device |
| ZA757570B (en) | 1974-12-09 | 1977-07-27 | Affiliated Med Res | A useful n-substituted pyridone |
| US4268460A (en) | 1977-12-12 | 1981-05-19 | Warner-Lambert Company | Nebulizer |
| US4253468A (en) | 1978-08-14 | 1981-03-03 | Steven Lehmbeck | Nebulizer attachment |
| US4263907A (en) | 1979-05-14 | 1981-04-28 | Lindsey Joseph W | Respirator nebulizer |
| US4510929A (en) | 1982-04-30 | 1985-04-16 | Bordoni Maurice E | Disposable radioactive aerosol inhalation apparatus |
| US4649911A (en) | 1983-09-08 | 1987-03-17 | Baylor College Of Medicine | Small particle aerosol generator for treatment of respiratory disease including the lungs |
| US4624251A (en) | 1984-09-13 | 1986-11-25 | Riker Laboratories, Inc. | Apparatus for administering a nebulized substance |
| US5152456A (en) | 1989-12-12 | 1992-10-06 | Bespak, Plc | Dispensing apparatus having a perforate outlet member and a vibrating device |
| US5164740A (en) | 1991-04-24 | 1992-11-17 | Yehuda Ivri | High frequency printing mechanism |
| ATE155695T1 (de) | 1991-11-07 | 1997-08-15 | Ritzau Pari Werk Gmbh Paul | Vernebler insbesondere zur anwendung in geräten für die inhalationstherapie |
| EP0615470B1 (en) | 1991-12-04 | 1995-12-13 | The Technology Partnership Public Limited Company | Fluid droplet production apparatus and method |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
| US5709202A (en) | 1993-05-21 | 1998-01-20 | Aradigm Corporation | Intrapulmonary delivery of aerosolized formulations |
| EP0810853B1 (en) | 1995-02-24 | 2004-08-25 | Elan Pharma International Limited | Aerosols containing nanoparticle dispersions |
| US5758637A (en) | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
| US6427682B1 (en) | 1995-04-05 | 2002-08-06 | Aerogen, Inc. | Methods and apparatus for aerosolizing a substance |
| US5586550A (en) | 1995-08-31 | 1996-12-24 | Fluid Propulsion Technologies, Inc. | Apparatus and methods for the delivery of therapeutic liquids to the respiratory system |
| US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
| US6083922A (en) | 1996-04-02 | 2000-07-04 | Pathogenesis, Corp. | Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis |
| US5906202A (en) | 1996-11-21 | 1999-05-25 | Aradigm Corporation | Device and method for directing aerosolized mist to a specific area of the respiratory tract |
| US6349719B2 (en) | 1997-02-24 | 2002-02-26 | Aradigm Corporation | Formulation and devices for monitoring the efficacy of the delivery of aerosols |
| DE19713636A1 (de) | 1997-04-02 | 1998-10-08 | Pari Gmbh | Atemzugsimulator |
| US5855564A (en) | 1997-08-20 | 1999-01-05 | Aradigm Corporation | Aerosol extrusion mechanism |
| DE69804832T2 (de) | 1997-10-08 | 2002-11-07 | Sepracor Inc., Marlborough | Dosierungsform zur verabreichung von aerosolen |
| DK0923957T3 (da) | 1997-11-19 | 2002-02-18 | Microflow Eng Sa | Dyseemne og væskedråbesprøjteindretning til en inhalator egnet til respirationsterapi |
| US6192876B1 (en) | 1997-12-12 | 2001-02-27 | Astra Aktiebolag | Inhalation apparatus and method |
| AU1226099A (en) | 1998-09-18 | 2000-04-10 | Mepha Ag | Topical formulation of alkyl-, phenyl-pyridone |
| GB2343122B (en) | 1998-10-26 | 2003-01-08 | Medic Aid Ltd | Improvements in and relating to nebulisers |
| US6070575A (en) | 1998-11-16 | 2000-06-06 | Aradigm Corporation | Aerosol-forming porous membrane with certain pore structure |
| US6584971B1 (en) | 1999-01-04 | 2003-07-01 | Medic-Aid Limited | Drug delivery apparatus |
| US6338443B1 (en) | 1999-06-18 | 2002-01-15 | Mercury Enterprises, Inc. | High efficiency medical nebulizer |
| US6962151B1 (en) | 1999-11-05 | 2005-11-08 | Pari GmbH Spezialisten für effektive Inhalation | Inhalation nebulizer |
| WO2001076671A2 (en) | 2000-04-11 | 2001-10-18 | Trudell Medical International | Aerosol delivery apparatus with positive expiratory pressure capacity |
| US6601581B1 (en) | 2000-11-01 | 2003-08-05 | Advanced Medical Applications, Inc. | Method and device for ultrasound drug delivery |
| DE10102846B4 (de) | 2001-01-23 | 2012-04-12 | Pari Pharma Gmbh | Aerosolgenerator |
| ATE298600T1 (de) | 2001-10-18 | 2005-07-15 | Pari Gmbh | Inhalationstherapievorrichtung |
| DE50102690D1 (de) | 2001-10-18 | 2004-07-29 | Pari Gmbh | Inhalationstherapievorrichtung |
| EP1438019A1 (en) | 2001-10-24 | 2004-07-21 | PARI GmbH Spezialisten für effektive Inhalation | Kit for the preparation of a pharmaceutical composition |
| US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
| JP4542743B2 (ja) * | 2002-12-26 | 2010-09-15 | Ｋｄｌ株式会社 | ピリドン誘導体の溶液状医薬組成物 |
| US7838532B2 (en) | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
| CN101848733A (zh) * | 2007-07-13 | 2010-09-29 | 艾博特生物技术有限公司 | 用于肺部给予TNFα抑制剂的方法和组合物 |
| EP2237788A4 (en) * | 2007-12-27 | 2013-06-05 | Aires Pharmaceuticals Inc | COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF |
| US8815838B2 (en) * | 2008-10-07 | 2014-08-26 | David C. Griffith | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| MX2012003644A (es) * | 2009-10-02 | 2012-04-30 | Astrazeneca Ab | Compuestos de 2-piridona empleados como inhibidores de la elastasa neutrofila. |
| JP6239054B2 (ja) * | 2010-11-26 | 2017-11-29 | 東芝メディカルシステムズ株式会社 | 磁気共鳴診断装置 |
| JP6021117B2 (ja) * | 2011-01-31 | 2016-11-02 | ジェノア ファーマシューティカルズ，インク． | エアロゾルのピルフェニドンおよびピリドンアナログの化合物、および、その使用 |
-
2013
- 2013-07-24 JP JP2015524425A patent/JP6501264B2/ja active Active
- 2013-07-24 NZ NZ705260A patent/NZ705260A/en unknown
- 2013-07-24 EP EP13822166.8A patent/EP2877164B1/en active Active
- 2013-07-24 AU AU2013295800A patent/AU2013295800A1/en not_active Abandoned
- 2013-07-24 HU HUE13822166A patent/HUE063581T2/hu unknown
- 2013-07-24 CA CA2880011A patent/CA2880011C/en active Active
- 2013-07-24 ES ES13822166T patent/ES2959198T3/es active Active
- 2013-07-24 WO PCT/US2013/051880 patent/WO2014018668A2/en not_active Ceased
-
2018
- 2018-06-19 JP JP2018116525A patent/JP2018172402A/ja active Pending
- 2018-07-23 AU AU2018206852A patent/AU2018206852A1/en not_active Abandoned
-
2019
- 2019-12-12 JP JP2019224873A patent/JP7120984B2/ja active Active
-
2020
- 2020-03-03 AU AU2020201557A patent/AU2020201557B2/en active Active
-
2022
- 2022-02-21 JP JP2022024945A patent/JP2022078126A/ja active Pending
- 2022-11-16 AU AU2022271417A patent/AU2022271417A1/en not_active Abandoned
-
2024
- 2024-03-14 JP JP2024040308A patent/JP2024095678A/ja active Pending
- 2024-11-29 AU AU2024267029A patent/AU2024267029A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020073494A5 (enExample) | ||
| JP2024095678A5 (enExample) | ||
| JP2018199688A5 (enExample) | ||
| JP2015523395A5 (enExample) | ||
| JP2019031514A5 (enExample) | ||
| JP2017502064A5 (enExample) | ||
| NZ760541A (en) | Aerosol pirfenidone and pyridone analog compounds and uses thereof | |
| JP6066350B2 (ja) | エアロゾルボーラスとしてのイロプロストの投与 | |
| JP2014503598A5 (enExample) | ||
| JP2017505348A (ja) | 肺疾患治療のための肥満細胞安定剤 | |
| JP2023542629A (ja) | 改良されたエアロゾルパラメータのための噴霧器デバイスの最適化及びその使用 | |
| EA022840B1 (ru) | Фармацевтическая композиция, набор, их применение и способ профилактики и лечения симптома, состояния или заболевания, связанного с инфекцией вируса гриппа | |
| WO2021212183A1 (en) | Products of manufacture and methods for treating, ameliorating or preventing microbial infections | |
| US20200222412A1 (en) | Methods and compositions for treating pulmonary hypertension | |
| HRP20221185T1 (hr) | Beta-ukosnica peptidomimetik s inhibitorskom aktivnošću elastase i njegovi oblici doziranja aerosolom | |
| Hsu et al. | Iloprost inhalation solution for the treatment of pulmonary arterial hypertension | |
| CN104853744B (zh) | 气溶胶化伊洛前列素的给药 | |
| Standaert et al. | The choice of compressor effects the aerosol parameters and the delivery of tobramycin from a single model nebulizer | |
| MX2013004030A (es) | Composicion farmaceutica a base de denufosol para tratar fibrosis quistica. | |
| WO2010009288A1 (en) | Compositions and uses of antiviral active pharmaceutical agents | |
| KR20230035518A (ko) | 선천적 면역 반응을 생성하기 위한 퀴닌과 그의 용도 | |
| US20240050374A1 (en) | Method and Composition for Treating Pulmonary Fibrosis | |
| CN107137502A (zh) | 一种鱼腥草雾化吸入用溶液制剂及其制备方法 | |
| US20250352530A1 (en) | Method and composition for treating lung diseases | |
| US20240424229A1 (en) | Aerosol delivery of pirfenidone |